Michael Allen Jerman Inhibitor Therapeutics, Inc. (INTI) insider trading activity
Michael Allen Jerman is Director of Inhibitor Therapeutics, Inc.. Currently has a direct ownership of 80,411 shares of INTI, which is worth approximately $7,236. The most recent transaction as insider was on Apr 01, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
80.4K
0%
3M change
n/a
12M change
Total Value Held
$7,236
Michael Allen Jerman Transaction History
Also insider at
MAJ
Michael Allen Jerman
Director
Miami, FL